Childhood Acute Basophilic Leukemia Terminated Phase 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0029228 (Childhood Acute Basophilic Leukemia)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00096148Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaTreatment